SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: charles sims who wrote (472)5/4/1998 9:47:00 AM
From: Biomaven  Read Replies (2) | Respond to of 2135
 
Well I sold my token 300 share investment at the open at an average of 78. Isn't biotech investing fun! I assumed my other cancer-related stocks (MOGN, PCYC) would go down, as they are apparently to be put out of business, but they appear to be up as well.

Peter



To: charles sims who wrote (472)5/4/1998 10:01:00 AM
From: Tummus1  Respond to of 2135
 
Charles
Uh, his name is Judah Folkman not Judith.
TW



To: charles sims who wrote (472)5/4/1998 12:28:00 PM
From: zebraspot  Read Replies (1) | Respond to of 2135
 
Charles Sims,

If you worked with Dr. Folkman, how come you referred to the Dr. as Judith, instead of Judah?

Care to defend your credibility?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News